(주)모아바이오

IBT Bioservices

[IBT Bioservices] rVSV-pseudotyped Ebola virus GP (rVSV-EBOV-GP)

Cat-No. 1001-001

IBT Bioservices는 감염병 및 면역 치료제 개발을 위한 비임상 연구 및

CRO(Contract Research Organization) 서비스를 제공하는 생명과학 기업입니다.

제품 설명

rVSV-pseudotyped Ebola virus GP (rVSV-EBOV-GP)

제품 번호

1001-001

제품 특징

Recombinant Vesicular Stomatitis Virus (rVSV) pseudotyped with Ebola virus glycoprotein (rVSV-EBOV-GP) system in which the G protein of VSV has been deleted, replaced with firefly luciferase and used to produce VSV-pseudotyped virus containing the envelope glycoprotein of Ebola virus. Since the infectivity of pseudotyped virus is restricted to a single round of replication, analyses of viral entry can be performed using just biosafety level 2 (BSL-2) containment.

Formulation & Storage: Supplied in EMEM™ (Gibco) supplemented with 1% Fetal Bovine Serum, Lglutamine and Penicillin/Streptomycin. Store at -80°C.
Notes & Usage Guidelines:
Recommended Dilution: 1:40
Luciferase Units for Assays: 30,000
Reporter: Luciferase

size: Sufficient for one 96-well plate